Rongrui Liang

613 total citations
23 papers, 520 citations indexed

About

Rongrui Liang is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Rongrui Liang has authored 23 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Epidemiology. Recurrent topics in Rongrui Liang's work include Liver Disease Diagnosis and Treatment (4 papers), MicroRNA in disease regulation (4 papers) and Cancer-related gene regulation (3 papers). Rongrui Liang is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), MicroRNA in disease regulation (4 papers) and Cancer-related gene regulation (3 papers). Rongrui Liang collaborates with scholars based in China, United States and Taiwan. Rongrui Liang's co-authors include Jun Yang, Shu Zhang, Peng An, Zongfang Li, Min Tao, Kai Chen, Jun Li, Kunlun Chen, Hongtao Ren and Yufeng Xie and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Experimental Cell Research.

In The Last Decade

Rongrui Liang

21 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongrui Liang China 11 267 153 112 91 90 23 520
Weili Min China 17 299 1.1× 132 0.9× 110 1.0× 98 1.1× 45 0.5× 26 591
Xiaodan Sun China 14 304 1.1× 113 0.7× 121 1.1× 56 0.6× 62 0.7× 39 556
Fengjun Cao China 16 355 1.3× 127 0.8× 136 1.2× 46 0.5× 63 0.7× 23 589
Yingqiu Zhang China 15 487 1.8× 225 1.5× 139 1.2× 48 0.5× 119 1.3× 31 772
Peng-Da Guo China 13 382 1.4× 140 0.9× 144 1.3× 93 1.0× 91 1.0× 18 644
In‐Chul Park South Korea 9 237 0.9× 125 0.8× 106 0.9× 49 0.5× 58 0.6× 10 459
Zhenhai Zhang China 12 254 1.0× 139 0.9× 138 1.2× 49 0.5× 83 0.9× 23 441
Taishu Wang China 10 427 1.6× 166 1.1× 115 1.0× 34 0.4× 90 1.0× 15 608
Zhan‐Qi Cao China 10 275 1.0× 112 0.7× 104 0.9× 36 0.4× 110 1.2× 14 528

Countries citing papers authored by Rongrui Liang

Since Specialization
Citations

This map shows the geographic impact of Rongrui Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongrui Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongrui Liang more than expected).

Fields of papers citing papers by Rongrui Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongrui Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongrui Liang. The network helps show where Rongrui Liang may publish in the future.

Co-authorship network of co-authors of Rongrui Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Rongrui Liang. A scholar is included among the top collaborators of Rongrui Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongrui Liang. Rongrui Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Wenqing, et al.. (2025). Implications of DNA damage response and immunotherapy in tumor therapy. Cell Communication and Signaling. 23(1). 518–518.
2.
Zhang, Yifan, Bin Hu, Jiadong Wang, et al.. (2025). Hollow spiky MnOx nanocarriers amplify radiotherapy-induced pyroptosis for eliciting antitumor immunity. Journal of Nanobiotechnology. 24(1). 19–19.
3.
4.
Gu, Quan, Yonghui Zhang, Yujie Gan, et al.. (2024). Rolapitant treats lung cancer by targeting deubiquitinase OTUD3. Cell Communication and Signaling. 22(1). 195–195. 7 indexed citations
5.
Liu, Shunan, Leying Zhang, Rongrui Liang, et al.. (2022). RAGE ablation attenuates glioma progression and enhances tumor immune responses by suppressing galectin-3 expression. Neuro-Oncology. 25(5). 886–898. 9 indexed citations
6.
Du, Jun, et al.. (2022). PRMT6 functionally associates with PRMT5 to promote colorectal cancer progression through epigenetically repressing the expression of CDKN2B and CCNG1. Experimental Cell Research. 422(1). 113413–113413. 10 indexed citations
7.
Zhang, Ian, Shunan Liu, Leying Zhang, et al.. (2022). IMMU-08. RAGE ABLATION ATTENUATES GLIOMA PROGRESSION AND ENHANCES TUMOR IMMUNE RESPONSES BY SUPPRESSING GALECTIN-3 EXPRESSION. Neuro-Oncology. 24(Supplement_7). vii132–vii133. 1 indexed citations
9.
Li, Daoming, et al.. (2021). Effect of palliative microwave ablation on metastatic osseous pain: a single-center retrospective study. Annals of Palliative Medicine. 10(9). 9725–9731. 4 indexed citations
10.
Xu, Caihua, Yu‐Feng Hu, Bin Chen, et al.. (2021). Metastasis-associated gene 1 (MTA1) enhances cisplatin resistance of malignant pleural mesothelioma by ATR-Chk1-mediated DNA repair. Annals of Translational Medicine. 9(8). 670–670. 6 indexed citations
11.
Zhao, Jing, Qiang Li, Dapeng Li, et al.. (2020). Effect of microwave ablation treatment of hepatic malignancies on serum cytokine levels. BMC Cancer. 20(1). 812–812. 23 indexed citations
12.
Li, Qiang, Qi Gui, Jing Zhao, et al.. (2020). Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression. Annals of Translational Medicine. 8(20). 1305–1305. 19 indexed citations
13.
Zha, Juanmin, Xiaofeng Xu, Dapeng Li, et al.. (2016). [Hypoxia promotes the growth and invasiveness of prostate cancer cells by down-regulating miR-132 in vitro].. PubMed. 22(12). 1071–1076. 2 indexed citations
14.
Li, Wei, Rongrui Liang, Chong Zhou, et al.. (2015). The association between expressions of Ras and CD68 in the angiogenesis of breast cancers. Cancer Cell International. 15(1). 17–17. 15 indexed citations
15.
Li, Wei, Mengyao Wu, Rongrui Liang, et al.. (2015). FH535 inhibited metastasis and growth of pancreatic cancer cells. OncoTargets and Therapy. 8. 1651–1651. 14 indexed citations
16.
Mao, Yixiang, Wei Li, Kai Chen, et al.. (2014). B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer. Oncotarget. 6(5). 3452–3461. 108 indexed citations
17.
Chen, Kunlun, Shu Zhang, Jun Li, et al.. (2013). Baicalein Inhibits the Invasion and Metastatic Capabilities of Hepatocellular Carcinoma Cells via Down-Regulation of the ERK Pathway. PLoS ONE. 8(9). e72927–e72927. 123 indexed citations
18.
Li, Hongliang, Shu Zhang, Yuan Wang, et al.. (2012). Baicalein induces apoptosis via a mitochondrial-dependent caspase activation pathway in T24 bladder cancer cells. Molecular Medicine Reports. 7(1). 266–270. 45 indexed citations
19.
Zhang, Shu, Manxiang Li, Chen Huang, et al.. (2012). NF-κB p65 and c-Rel subunits promote phagocytosis and cytokine secretion by splenic macrophages in cirrhotic patients with hypersplenism. The International Journal of Biochemistry & Cell Biology. 45(2). 335–343. 22 indexed citations
20.
Wang, Juan, Shu Zhang, Zongfang Li, et al.. (2010). 1H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasis. Tumor Biology. 32(1). 223–231. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026